ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Pepperstone

Trade Now

Pepperstone
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P ASX 200
8,220.90
0.24%
S&P ASX All Technology
3,825.10
-0.11%
Brent Oil
73.285
0.80%
US Dollar vs AUD
1.60385
0.14%
Bitcoin
98,637.76
4.17%
Pepperstone
Advertisement
Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. Brazil
  5. BOV

  6. Alnylam Pharmaceuticals Inc (A1LN34) Share Price

Alnylam Pharmaceuticals Inc

Alnylam Pharmaceuticals Inc (A1LN34)

BOV
73.85
0.35
(0.48%)
Closed 25 December 7:55AM
Delayed by 15 minutes

Empower your portfolio: Real-time discussions and actionable trading ideas.

Premium

Key stats and details

Current Price
73.85
Bid
10.00
Offer
0.00
Volume
261
73.36 Day's Range 73.85
36.23 52 Week Range 85.44
Market Cap
9.268B
Previous Close
73.50
Open
73.36
Last Trade
1
@
73.85
Last Trade Time
Financial Volume
R$ 19,147
VWAP
73.362
Average Volume (3m)
189
Shares Outstanding
125,493,000
Dividend Yield
-
PE Ratio
-69.34
Earnings Per Share (EPS)
-3.51
Revenue
1.83B
Net Profit
-440.24M

About Alnylam Pharmaceuticals Inc

Sector
Pharmaceutical Preparations
Industry
Pharmaceutical Preparations
Website
www.alnylam.com
Headquarters
Wilmington, Delaware, USA
Founded
-
Alnylam Pharmaceuticals Inc is listed in the Pharmaceutical Preparations sector of the Brazil Bovespa Exchange with ticker A1LN34. The last closing price for Alnylam Pharmaceuticals was R$73.50. Over the last year, Alnylam Pharmaceuticals shares have traded in a share price range of R$ 36.23 to R$ 85.44.

Alnylam Pharmaceuticals currently has 125,493,000 shares in issue. The market capitalisation of Alnylam Pharmaceuticals is R$9.22 billion. Alnylam Pharmaceuticals has a price to earnings ratio (PE ratio) of -69.34.

Ask ADVFN Intelligence (AI)

A1LN34 Latest News

More News
No news to show yet.
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1-0.56-0.75258701787474.4175.472.118374.25299014DR
40.851.164383561647377.6871.4124274.7658509DR
12-1.33-1.7690875232875.1885.4466.518974.87731042DR
2627.5859.606656580946.2785.4446.2731574.49802624DR
5225.9354.111018363947.9285.4436.2325074.29105282DR
15619.5836.078864934654.2785.4429.8544752.88784555DR
26032.980.341880341940.9585.4429.8549150.54253841DR

A1LN34 - Frequently Asked Questions (FAQ)

What is the current Alnylam Pharmaceuticals share price?
The current share price of Alnylam Pharmaceuticals is R$ 73.85
How many Alnylam Pharmaceuticals shares are in issue?
Alnylam Pharmaceuticals has 125,493,000 shares in issue
What is the market cap of Alnylam Pharmaceuticals?
The market capitalisation of Alnylam Pharmaceuticals is BRL 9.22B
What is the 1 year trading range for Alnylam Pharmaceuticals share price?
Alnylam Pharmaceuticals has traded in the range of R$ 36.23 to R$ 85.44 during the past year
What is the PE ratio of Alnylam Pharmaceuticals?
The price to earnings ratio of Alnylam Pharmaceuticals is -69.34
What is the cash to sales ratio of Alnylam Pharmaceuticals?
The cash to sales ratio of Alnylam Pharmaceuticals is 16.7
What is the reporting currency for Alnylam Pharmaceuticals?
Alnylam Pharmaceuticals reports financial results in USD
What is the latest annual turnover for Alnylam Pharmaceuticals?
The latest annual turnover of Alnylam Pharmaceuticals is USD 1.83B
What is the latest annual profit for Alnylam Pharmaceuticals?
The latest annual profit of Alnylam Pharmaceuticals is USD -440.24M
What is the registered address of Alnylam Pharmaceuticals?
The registered address for Alnylam Pharmaceuticals is 1209 ORANGE STREET, WILMINGTON, DELAWARE, 19801
What is the Alnylam Pharmaceuticals website address?
The website address for Alnylam Pharmaceuticals is www.alnylam.com
Which industry sector does Alnylam Pharmaceuticals operate in?
Alnylam Pharmaceuticals operates in the PHARMACEUTICAL PREPARATIONS sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
COCE11Cia Energetica Ceara Coelce
R$ 1.15
(342.31%)
130k
ESTR4Manufatura Brinquedos Estrela Sa
R$ 4.98
(39.89%)
200
AZEV11Azevedo Travassos Sa
R$ 0.24
(20.00%)
30.4k
OSXB3OSX Brasil SA
R$ 3.80
(11.44%)
2.6k
AMBP3Ambipar Participacoes e Empreendimentos SA
R$ 140.00
(10.24%)
214.9k
TKNO3Tekno Sa Ind Com
R$ 40.70
(-45.73%)
9.8k
IFCM3Infracommerce Caxaas S.A.
R$ 0.06
(-33.33%)
50.97M
TKNO4Tekno Sa Ind Com
R$ 55.20
(-20.00%)
7.7k
AMOB3Automob Participacoes Sa
R$ 0.34
(-19.05%)
68.21M
CBEE3Ampla Energia Servicos Sa
R$ 10.01
(-16.58%)
600
HAPV3Hapvida Participacoes Investimento SA
R$ 2.25
(-5.46%)
70.23M
AMOB3Automob Participacoes Sa
R$ 0.34
(-19.05%)
68.21M
IFCM3Infracommerce Caxaas S.A.
R$ 0.06
(-33.33%)
50.97M
PETR4Petroleo Brasileiro S.A. Petrobras
R$ 36.86
(0.027137%)
43.79M
ABEV3Ambev SA
R$ 12.22
(-0.08%)
40.18M

Discussion

View Full Feed
northam43 northam43 2 minutes ago
Report # 6.1 SPX Cycles Short Range Chart (60 min & Daily Cycles)

https://investorshub.advfn.com/uimage/uploads/2024/12/24/kpoid6.1_Short_Term.png
martyDg martyDg 3 minutes ago
How can they sell the company if they can't even secure UK approval, especially when that's under LP's domain? The MHRA is just as slow as NWBO's management. If they can't get approval from the UK, imagine how long it would take to get approval from the US FDA—they'd probably leave the paperwork sit
NWBO
nilremerlin nilremerlin 3 minutes ago
50 dma now up to .60 above the 200 dma, further confirming the integrity of the Golden Cross.
VWAP 3.13 US, uP today.
Close $3.14 US, uP today.
Volume was less than the average today.
$3 US VWAP close was achieved on
10/29/24.
Above $3 US VWAP close achieved
HITI
againstallodds againstallodds 4 minutes ago
PDIV A TOXIC SHARE SELLING SCAM
PDIV
Edward Edward 5 minutes ago
Funny, i am blocked and still my posts are read. LOL!


Criminal charges are coming!


The SEC has extremely broad investigative and enforcement powers, it cannot file criminal charges. It can, and often does, work with the Department of Justice and the Unit
VXIT
northam43 northam43 5 minutes ago
Report #6 SPX All Cycles Chart.

https://investorshub.advfn.com/uimage/uploads/2024/12/24/enjxe6_All_Cycles_Chart.png
gedi8 gedi8 6 minutes ago
Back at you my friend.
NXPL
nunaka nunaka 6 minutes ago
You always sound like such a petty, silly kid.
RDGL
mailman69 mailman69 8 minutes ago
Left a word out
I agree with you
It tends to post misleading information in my opinion
VXIT
searay2701 searay2701 8 minutes ago
What a present for Christmas, thank you Lord and everyone who said basically hang in here, they were right on. Hopefully we will see a continual revenue increase per quarter to quarter in 2025 and we will know for sure, going ahead, that things have changed with IVDN LAND for good.
Merry C
IVDN
Shareing is winning Shareing is winning 8 minutes ago
Oops! Something gone wrong here!
Our engineers have noticed the problem and we are working on it now!

In the meantime, try logging out, clearing your cookies and cache for advfn.com (most browsers will let you clear a single domain instead of clearing all your cookies), then l
georgie18 georgie18 9 minutes ago
Happy Holidays Y'all...🥳
jimr1717 jimr1717 9 minutes ago
Quick buy two shares and get this pig painted
NFTM
georgie18 georgie18 9 minutes ago
Happy Holidays Y'all...🥳
igotthemojo igotthemojo 9 minutes ago
"IGTM, it has bipartisan support"

it has a few self serving politicians whose districts will benefit that are for it...that isnt "bipartisan support"...

"creates manufacturing jobs in the US"

so does chewing gum...its not an issue anyone really cares abou
PLUG
NeoSunTzu NeoSunTzu 9 minutes ago
You overreact without having the information you need to make intelligent relevant remarks with just about every discussion on this board. READ THE ARTICLE! This NOT just banks, but other organizations like Chambers of Commerce and other business groups, who are looking NOT to eliminate stress tests
FNMA
jimr1717 jimr1717 10 minutes ago
It really doesn’t matter. No one is short this scam.
IFUS
tat4tat tat4tat 10 minutes ago
There they go again with talking around the main issues with redundant BS. What new avenues. Maybe they mean Conquer sales; or mushroom coffee. Will the CEO start marketing posters of herself for the masses. What about the Q being filed, or is that just a frivolous matter to them. Why are they not a
CEOS
martyDg martyDg 10 minutes ago
NWBO is largely done with getting BLA ready for FDA; they just want to apply any minor modifications learned from MHRA submission

Why don't they issue a pr stating that they are in the process of preparing the BLA submission, as they did with the MAA submission? No news means you're f
NWBO
3Angels120702 3Angels120702 10 minutes ago
Not the first OTC scam I've run into
MWWC
MasterBlastr MasterBlastr 11 minutes ago
Alliance of Diehards, Season 2 Week #18
Alliance of Diehards, Season 2 ends Dec 31, 2024
There are no plans for Season 3, but I will instead create contests that are open to all Draftkings members.

DP World Tour Fantasy League for 2025 has begun - https://
Paulie Pennies Paulie Pennies 11 minutes ago
Merry Christmas folks 😎
ASII
sloppyjones sloppyjones 11 minutes ago
11:59.59 tonight. Lol

Merry Christmas everyone!
TPTW
Pineywoods Pineywoods 12 minutes ago
Now that has a good ring to it!  Go BIEL $$
BIEL

Your Recent History

BOV
A1LN34
Alnylam Pharmaceuticals
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Australia
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved

Go Ad-Free

Subscribe to Ad free and enjoy an ad-free experience

No Ads

Try Now

Keep the Ads